EVAX Evaxion A/S

European equities traded in the US as American depositary receipts were tracking modestly higher lat

European equities traded in the US as American depositary receipts were tracking lower Wednesday mor

European equities traded in the US as American depositary receipts Tuesday were tracking lower Tuesd

European equities traded in the US as American depositary receipts were heading lower late Friday mo

European equities traded in the US as American depositary receipts edged higher late Wednesday morni

European equities traded in the US as American depositary receipts were trending lower late Thursday

European equities traded in the US as American depositary receipts were trending lower late Wednesda

European equities traded in the US as American depositary receipts were tracking lower late Tuesday

European equities traded in the US as American depositary receipts were marginally higher late Frida

European equities traded in the US as American depositary receipts were edging higher late Thursday

European equities traded in the US as American depositary receipts were trending higher late Wednesd

European equities traded in the US as American depositary receipts opened the week slightly lower la

Merck (NYSE: MRK) disclosed an equity stake in Evaxion A/S tied to an AI powered vaccine program centered on candidate EVX-B3. The company in licensed EVX-B3, an AI guided vaccine candidate, as part of its push into AI driven vaccine discovery. The move extends Merck's use of artificial intelligence beyond its existing focus on traditional pharmaceuticals and mRNA oncology research. Readers who want more ideas at the intersection of healthcare and artificial intelligence may also want to...

Evaxion AS (EVAX) reports a net loss of $3.7 million for Q2 2026, with a cash runway into H2 2027, as positive clinical data and industry validation strengthen its AI-driven cancer vaccine programs.

In a regulatory filing on August 10, pharmaceutical titan Merck & Company, Inc. (NYSE:MRK) disclosed holding 1,214,126 shares of micro-cap AI immunology firm Evaxion A/S (NASDAQ:EVAX). Evaxion shares bumped up 2% to $3.17 in early trading on the news. The position follows Merck’s September 2025 decision to exercise its option to in-license EVX-B3, Evaxion’s discovery-stage […]

European equities traded in the US as American depositary receipts were tracking higher late Thursda

European equities traded in the US as American depositary receipts were tracking higher late Wednesd

European equities traded in the US as American depositary receipts were trending lower in late Tuesd

European equities traded in the US as American depositary receipts were tracking lower late Friday m

European equities traded in the US as American depositary receipts were higher late Thursday morning

European equities traded in the US as American depositary receipts were edging lower late Wednesday

European equities traded in the US as American depositary receipts started the week modestly higher